Wei Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wei Guo has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
Tao Bao
Army Medical Center of People’s Liberation Amry of China (Daping Hospital)
23 shared publicationsKun-Kun Li
Army Medical Center of People’s Liberation Amry of China (Daping Hospital)
19 shared publicationsYing-Jian Wang
Army Medical Center of People’s Liberation Amry of China (Daping Hospital)
17 shared publicationsXue-Hai Liu
Army Med Univ, Daping Hosp, Dept Thorac Surg, Chongqing, Peoples R China
10 shared publicationsXian-Dong He
Army Medical Center of People’s Liberation Amry of China (Daping Hospital)
9 shared publicationsXian-Feng Xie
Army Medical Center of People’s Liberation Amry of China (Daping Hospital)
9 shared publications
Latest Publications
- 30 October 2026
- Published by Taylor & Francis in Future Oncology
- p. 1-10
Protocol for a multicenter prospective phase II trial of adjuvant tislelizumab combined with S-1 in subjects with residual primary lesions and node-negative esophageal squamous cell carcinoma (PPIO-008)
1. Esophageal cancer (EC) is a globally prevalent malignant tumor, with its incidence ranking seventh among all types of cancer worldwide and its mortality ranking sixth in cancer-related deaths [1...
- 30 October 2026
- Published by Taylor & Francis in Future Oncology
- p. 1-10
Protocol for a multicenter prospective phase II trial of adjuvant tislelizumab combined with S-1 in subjects with residual primary lesions and node-negative esophageal squamous cell carcinoma (PPIO-008)
1. Esophageal cancer (EC) is a globally prevalent malignant tumor, with its incidence ranking seventh among all types of cancer worldwide and its mortality ranking sixth in cancer-related deaths [1...
- 23 July 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (10) , 8630-8640
Type 2 diabetes mellitus confers unfavorable short- and long-term outcomes in patients undergoing esophagectomy
- 23 July 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (10) , 8630-8640
Type 2 diabetes mellitus confers unfavorable short- and long-term outcomes in patients undergoing esophagectomy
- Open Access
- 29 October 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-11
Comparing radiomics, deep learning, and fusion models for predicting occult pleural dissemination in patients with non-small cell lung cancer: a retrospective multicenter study
Occult pleural dissemination (PD) in non-small cell lung cancer (NSCLC) patients is likely to be missed on computed tomography (CT) scans, associated with poor survival, and generally contraindicated for radical surgery. This study aimed to develop and compare the performance of radiomics-based machine learning (ML), deep learning (DL), and fusion models to preoperatively identify occult PD in NSCLC patients. A total of 326 NSCLC patients from three Chinese high-volume medical centers (2016–2023) were retrospectively collected and divided into training (n = 216), internal test (n = 54), and external test (n = 56) cohorts. Ten radiomics-based ML models and eight DL models were trained using CT images at the maximum cross-sectional slice of the primary tumor. Moreover, another two fusion models (prefusion and postfusion) were developed using feature-based and decision-based methods. The receiver operating characteristic curve (ROC) and area under the curve (AUC) were mainly used to compare the predictive performance of the models. The GBM (AUC: 0.821) and DenseNet121 (AUC: 0.764) models achieved the highest AUC among ML and DL models in the external test cohorts, respectively. The postfusion model, integrating the output probabilities from GBM and DenseNet121 models, showed superior performance (AUC: 0.828–0.978) compared to the prefusion model (AUC: 0.817–0.877). Moreover, the postfusion model demonstrated the highest degree of sensitivity (82.1–97.2%) among all models across the three cohorts. The postfusion model, which integrates radiomics-based ML and DL models, can serve as a sensitive diagnostic tool to predict occult PD in NSCLC patients, thereby helping to avoid unnecessary surgeries.
- 29 October 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-11
Open AccessComparing radiomics, deep learning, and fusion models for predicting occult pleural dissemination in patients with non-small cell lung cancer: a retrospective multicenter study
Occult pleural dissemination (PD) in non-small cell lung cancer (NSCLC) patients is likely to be missed on computed tomography (CT) scans, associated with poor survival, and generally contraindicated for radical surgery. This study aimed to develop and compare the performance of radiomics-based machine learning (ML), deep learning (DL), and fusion models to preoperatively identify occult PD in NSCLC patients. A total of 326 NSCLC patients from three Chinese high-volume medical centers (2016–2023) were retrospectively collected and divided into training (n = 216), internal test (n = 54), and external test (n = 56) cohorts. Ten radiomics-based ML models and eight DL models were trained using CT images at the maximum cross-sectional slice of the primary tumor. Moreover, another two fusion models (prefusion and postfusion) were developed using feature-based and decision-based methods. The receiver operating characteristic curve (ROC) and area under the curve (AUC) were mainly used to compare the predictive performance of the models. The GBM (AUC: 0.821) and DenseNet121 (AUC: 0.764) models achieved the highest AUC among ML and DL models in the external test cohorts, respectively. The postfusion model, integrating the output probabilities from GBM and DenseNet121 models, showed superior performance (AUC: 0.828–0.978) compared to the prefusion model (AUC: 0.817–0.877). Moreover, the postfusion model demonstrated the highest degree of sensitivity (82.1–97.2%) among all models across the three cohorts. The postfusion model, which integrates radiomics-based ML and DL models, can serve as a sensitive diagnostic tool to predict occult PD in NSCLC patients, thereby helping to avoid unnecessary surgeries.
- 3 October 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (1) , 137-144
Prolonged postoperative mechanical ventilation is associated with a decrease in anastomotic leak following esophagectomy
Background Anastomotic leak (AL) is a severe complication after minimally invasive esophagectomy (MIE). Oxygen therapy is expected to reduce its incidence. However, when and how to conduct oxygen therapy and whether it reduces anastomotic leak incidence is unclear. Method We retrospectively analyzed the oxygenation index (OI) of 75 patients with esophageal cancer after MIE in our hospital. Trends of OI changes were depicted. According to mechanical ventilation duration, patients were divided into Prolonged Postoperative Mechanical Ventilation (PPMV) (≥ 24 h) and Non-Prolonged Postoperative Mechanical Ventilation (NPMV) (< 24 h) groups. The effect of PPMV on OI was analyzed; the number of analyzable cases was expanded to 312, and 89 cases each of PPMV and NPMV were obtained by Propensity Score Matching (PSM). The incidences of AL and other complications were compared between the two groups. Results OI significantly decreased on POD1 and 2. OI in AL group was higher on POD1 and showed a more dramatic decrease on POD 2. Patients in PPMV group had a moderate OI decrease on POD 2 and lower AL rate. Expanding cases to 312, AL rate in PPMV group was significantly lower than NPMV group (8.08% vs 23.47%, p = 0.001). After PSM, the difference in AL rate remained significant (7.88% vs 24.71%, p = 0.004). The pulmonary infection and pleural effusion incidence was lower in PPMV group. Conclusion The sharp decline of OI on POD 2 may cause AL following MIE. Prolonging postoperative mechanical ventilation to 24 h may help moderate the decline in OI and potentially reduce the incidence of anastomotic leakage. Graphical abstract
- 3 October 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (1) , 137-144
Prolonged postoperative mechanical ventilation is associated with a decrease in anastomotic leak following esophagectomy
Background Anastomotic leak (AL) is a severe complication after minimally invasive esophagectomy (MIE). Oxygen therapy is expected to reduce its incidence. However, when and how to conduct oxygen therapy and whether it reduces anastomotic leak incidence is unclear. Method We retrospectively analyzed the oxygenation index (OI) of 75 patients with esophageal cancer after MIE in our hospital. Trends of OI changes were depicted. According to mechanical ventilation duration, patients were divided into Prolonged Postoperative Mechanical Ventilation (PPMV) (≥ 24 h) and Non-Prolonged Postoperative Mechanical Ventilation (NPMV) (< 24 h) groups. The effect of PPMV on OI was analyzed; the number of analyzable cases was expanded to 312, and 89 cases each of PPMV and NPMV were obtained by Propensity Score Matching (PSM). The incidences of AL and other complications were compared between the two groups. Results OI significantly decreased on POD1 and 2. OI in AL group was higher on POD1 and showed a more dramatic decrease on POD 2. Patients in PPMV group had a moderate OI decrease on POD 2 and lower AL rate. Expanding cases to 312, AL rate in PPMV group was significantly lower than NPMV group (8.08% vs 23.47%, p = 0.001). After PSM, the difference in AL rate remained significant (7.88% vs 24.71%, p = 0.004). The pulmonary infection and pleural effusion incidence was lower in PPMV group. Conclusion The sharp decline of OI on POD 2 may cause AL following MIE. Prolonging postoperative mechanical ventilation to 24 h may help moderate the decline in OI and potentially reduce the incidence of anastomotic leakage. Graphical abstract
- 4 September 2025
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 29 (11) , 102219
Three-year outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with locally advanced esophageal squamous cell carcinoma: a real-world retrospective study
- 4 September 2025
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 29 (11) , 102219
Three-year outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with locally advanced esophageal squamous cell carcinoma: a real-world retrospective study
- Open Access
- 29 August 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-3
Correction: Primary tumour resection in non-small cell lung cancer patients with pleural dissemination unexpectedly detected during operation: a two-centre retrospective cohort study
- 29 August 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-3
Open AccessCorrection: Primary tumour resection in non-small cell lung cancer patients with pleural dissemination unexpectedly detected during operation: a two-centre retrospective cohort study
- Open Access
- 1 July 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Comparison of double-layered scallop-shaped anastomosis and circular stapled anastomosis in Ivor–Lewis surgery for esophageal and EGJ cancer: a retrospective cohort study
Cancers of the lower esophagus and esophagogastric junction (EGJ) are highly aggressive and have poor prognoses. Minimally invasive Ivor–Lewis surgery (MIIL) is the preferred treatment, but anastomotic leakage (AL) remains a critical complication of this procedure. In the present study, we introduce a novel double-layered scallop-shaped anastomosis (DLSSA) technique and compare its outcomes with those of circular stapled esophagogastric anastomosis (CSEA). From April 2016 to February 2023, 117 patients with distal esophageal or EGJ cancer who underwent complete thoracoscopic–laparoscopic Ivor–Lewis surgery were retrospectively analyzed. Patients were divided into DLSSA (n = 50) and CSEA (n = 67) groups. The median value and ranges are used to present the numerical data. Continuous and categorical variables were compared between groups with the Kruskal‒Wallis test and Fisher’s exact test or χ2 test, respectively. Multivariable binary logistic regression analyses were performed to identify potential prognostic factors. The median total operation duration was similar between the groups (280 min). Intraoperative blood loss was slightly greater in the CSEA group (120 ml vs. 100 ml, p = 0.001). Postoperative complications occurred in 32.5% of the patients, with no significant between-group difference. However, the incidence of AL was significantly lower (4.0% vs. 17.9%, p = 0.022) and that of pleural effusion was significantly greater (10.0% vs. 1.5%, p = 0.039) in the DLSSA group than in the CSEA group. Multivariable analysis revealed that a higher body mass index (OR = 1.453, 95% CI: 1.119–1.888; p = 0.005) was a risk factor for AL, whereas undergoing DLSSA was associated with reduced AL risk (OR = 0.052, 95% CI: 0.005–0.525; p = 0.012), and both variables were considered independent predictors of AL risk. Compared with CSEA, DLSSA was associated with significantly lower risk of AL in thoracoscopic Ivor–Lewis surgery, demonstrating its potential as a safer anastomotic technique. However, its association with increased pleural effusion warrants further investigation. Prospective randomized trials are needed to validate long-term outcomes and optimize procedural efficacy.
- 1 July 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Open AccessComparison of double-layered scallop-shaped anastomosis and circular stapled anastomosis in Ivor–Lewis surgery for esophageal and EGJ cancer: a retrospective cohort study
Cancers of the lower esophagus and esophagogastric junction (EGJ) are highly aggressive and have poor prognoses. Minimally invasive Ivor–Lewis surgery (MIIL) is the preferred treatment, but anastomotic leakage (AL) remains a critical complication of this procedure. In the present study, we introduce a novel double-layered scallop-shaped anastomosis (DLSSA) technique and compare its outcomes with those of circular stapled esophagogastric anastomosis (CSEA). From April 2016 to February 2023, 117 patients with distal esophageal or EGJ cancer who underwent complete thoracoscopic–laparoscopic Ivor–Lewis surgery were retrospectively analyzed. Patients were divided into DLSSA (n = 50) and CSEA (n = 67) groups. The median value and ranges are used to present the numerical data. Continuous and categorical variables were compared between groups with the Kruskal‒Wallis test and Fisher’s exact test or χ2 test, respectively. Multivariable binary logistic regression analyses were performed to identify potential prognostic factors. The median total operation duration was similar between the groups (280 min). Intraoperative blood loss was slightly greater in the CSEA group (120 ml vs. 100 ml, p = 0.001). Postoperative complications occurred in 32.5% of the patients, with no significant between-group difference. However, the incidence of AL was significantly lower (4.0% vs. 17.9%, p = 0.022) and that of pleural effusion was significantly greater (10.0% vs. 1.5%, p = 0.039) in the DLSSA group than in the CSEA group. Multivariable analysis revealed that a higher body mass index (OR = 1.453, 95% CI: 1.119–1.888; p = 0.005) was a risk factor for AL, whereas undergoing DLSSA was associated with reduced AL risk (OR = 0.052, 95% CI: 0.005–0.525; p = 0.012), and both variables were considered independent predictors of AL risk. Compared with CSEA, DLSSA was associated with significantly lower risk of AL in thoracoscopic Ivor–Lewis surgery, demonstrating its potential as a safer anastomotic technique. However, its association with increased pleural effusion warrants further investigation. Prospective randomized trials are needed to validate long-term outcomes and optimize procedural efficacy.
- 20 April 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (7) , 4705-4706
ASO Author Reflections: Tumor Location and TRG in Neoadjuvant Immunotherapy for Esophageal Cancer
- 20 April 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (7) , 4705-4706
ASO Author Reflections: Tumor Location and TRG in Neoadjuvant Immunotherapy for Esophageal Cancer
- 26 March 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (7) , 4670-4680
Patients with Upper Third of Esophageal Squamous Cell Carcinoma Have Better Tumor Regression After Neoadjuvant Immunochemotherapy
Several high-quality clinical trials have shown promising results compared with neoadjuvant chemotherapy (NCT) or chemoradiotherapy, further supporting the
- 26 March 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (7) , 4670-4680
Patients with Upper Third of Esophageal Squamous Cell Carcinoma Have Better Tumor Regression After Neoadjuvant Immunochemotherapy
Several high-quality clinical trials have shown promising results compared with neoadjuvant chemotherapy (NCT) or chemoradiotherapy, further supporting the
- Open Access
- 21 February 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Primary tumour resection in non-small cell lung cancer patients with pleural dissemination unexpectedly detected during operation: a two-centre retrospective cohort study
There is no consensus regarding whether primary tumour resection (PTR) should be performed in non-small cell lung cancer (NSCLC) patients with unexpected pleural dissemination (PD) discovered at thoracotomy. Consecutive NSCLC patients with surgically confirmed PD were retrospectively enrolled from two high-volume centres between January 2016 and December 2023. Patients were divided into the primary tumour resection (PTR) and exploratory thoracotomy (ET) group. PTR included wedge resection, segmentectomy and lobectomy. Patients in the ET group received biopsy only. Propensity score matching (PSM) was used to reduce selection bias from confounding factors. Disease-specific survival (DSS) and progression-free survival (PFS) were analysed using the Kaplan‒Meier method, and comparisons were made using the log-rank test. Multivariate Cox regression analyses were performed to identify the independent prognostic factors. A total of 223 patients were identified: 167 (74.9%) in the PTR group and 56 (25.1%) in the ET group. The median follow-up time and median survival time (MST) were 39.0 months and 49.0 months, respectively. The MST for the ET and PTR groups were 44.0 and 60.0 months, respectively (HR 0.80, 95% CI 0.51–1.24; p = 0.3097). After PSM, there were no significant differences in terms of median disease-specific survival (DSS: 60.0 vs. 61.0 months, p = 0.3419) or progression-free survival (PFS: 30.0 vs. 47.0 months, p = 0.5471) between the two groups. Multivariate analysis revealed that smoking history and a tumour size ≥ 3 cm were independent risk factors for DSS and PFS, whereas targeted therapy was an independent protective factor. Our results suggest that primary tumour resection does not improve long-term survival in NSCLC patients with unexpected PD discovered at thoracotomy. It is high time to re-evaluate the value of surgery for NSCLC patients with PD and avoid overtreatment, especially in the era of targeted therapy and immunotherapy. ClinicalTrials.gov NCT06232967 (approval date: January 31, 2024).
- 21 February 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Open AccessPrimary tumour resection in non-small cell lung cancer patients with pleural dissemination unexpectedly detected during operation: a two-centre retrospective cohort study
There is no consensus regarding whether primary tumour resection (PTR) should be performed in non-small cell lung cancer (NSCLC) patients with unexpected pleural dissemination (PD) discovered at thoracotomy. Consecutive NSCLC patients with surgically confirmed PD were retrospectively enrolled from two high-volume centres between January 2016 and December 2023. Patients were divided into the primary tumour resection (PTR) and exploratory thoracotomy (ET) group. PTR included wedge resection, segmentectomy and lobectomy. Patients in the ET group received biopsy only. Propensity score matching (PSM) was used to reduce selection bias from confounding factors. Disease-specific survival (DSS) and progression-free survival (PFS) were analysed using the Kaplan‒Meier method, and comparisons were made using the log-rank test. Multivariate Cox regression analyses were performed to identify the independent prognostic factors. A total of 223 patients were identified: 167 (74.9%) in the PTR group and 56 (25.1%) in the ET group. The median follow-up time and median survival time (MST) were 39.0 months and 49.0 months, respectively. The MST for the ET and PTR groups were 44.0 and 60.0 months, respectively (HR 0.80, 95% CI 0.51–1.24; p = 0.3097). After PSM, there were no significant differences in terms of median disease-specific survival (DSS: 60.0 vs. 61.0 months, p = 0.3419) or progression-free survival (PFS: 30.0 vs. 47.0 months, p = 0.5471) between the two groups. Multivariate analysis revealed that smoking history and a tumour size ≥ 3 cm were independent risk factors for DSS and PFS, whereas targeted therapy was an independent protective factor. Our results suggest that primary tumour resection does not improve long-term survival in NSCLC patients with unexpected PD discovered at thoracotomy. It is high time to re-evaluate the value of surgery for NSCLC patients with PD and avoid overtreatment, especially in the era of targeted therapy and immunotherapy. ClinicalTrials.gov NCT06232967 (approval date: January 31, 2024).